Today, Siemens Healthcare Diagnostics Inc. announced plans to release a
genetic assay designed to test for the presence of the Zika virus. A
genetic test is capable of identifying the presence of a virus prior to
the development of antibodies, so it can be an earlier indicator of
infection. Declared a Global Health Emergency by the World Health
Organization (WHO) as of February 1st, the current Zika
outbreak is characterized by explosive growth across South and Central
America, the Caribbean, and the United States.